|Year : 2020 | Volume
| Issue : 1 | Page : 191
Association of Vitamin D deficiency with cardiovascular disease among Saudi patients in Saudi Arabia
Salem Jabbar Hamdan Alghamdi1, Eltigani O M. Omer2, Mubashir Zafar2, Hatem Khader Ibrahim Herzallah2
1 Department of Public Health, Yadam General Hospital, Ministry of Health, Najran, KSA
2 Department of Public Health, College of Public Health, Imamm Abdul Rehman Bin Faisal University, Dammam, KSA
|Date of Submission||25-Sep-2019|
|Date of Acceptance||21-Nov-2019|
|Date of Web Publication||11-Dec-2020|
Department of Public Health, College of Public Health, Imamm Abdul Rehman Bin Faisal University, Dammam
Source of Support: None, Conflict of Interest: None
Background: Vitamin D deficiency has a far-reaching impact on several metabolic functions including cardiovascular health. This study aimed to test the association of serum 25 [OH]-vitamin D3 levels among cardiovascular disease (i.e., hypertension and ischemic heart disease) patients. Methods: A cross-sectional study was conducted among 360 participants from the tertiary care hospital. The simple random technique was used to select the participants. Only Saudi nationals were included in the study. Sociodemographic information, nutritional status, biochemical parameter (lipid profile, blood glucose level), and questions relating to cardiovascular disease were collected from the hospital record through data collection sheet. Serum Vit D level was determined by serum 25 (OH) blood test. Statistical package for social science (SPSS) software version 24 was used for data analysis. Binary logistic regression model was fitted to indentify the associated factors of vitamin D deficiency among cardiovascular disease patients. Results: Approximately 40.6% and 27.8% of study participants had vitamin D deficiency and insufficiency, respectively. After adjustment of covariates, among cardiac patients, vitamin D deficiency was associated with ischemic heart disease (OR 2.24, 95% CI 1.11–4.52), and blood triglyceride level (OR 2.27, 95% CI 1.22–4.22). Conclusions: Vitamin D deficiency and insufficiency are associated with ischemic heart disease, hyperglycemia, and hypertriglyceridemia. There is a need for the screening of cardiovascular disease patients for vitamin D levels.
Keywords: Abnormality, blood, heart, patients, vitamin D
|How to cite this article:|
Hamdan Alghamdi SJ, M. Omer EO, Zafar M, Ibrahim Herzallah HK. Association of Vitamin D deficiency with cardiovascular disease among Saudi patients in Saudi Arabia. Int J Prev Med 2020;11:191
|How to cite this URL:|
Hamdan Alghamdi SJ, M. Omer EO, Zafar M, Ibrahim Herzallah HK. Association of Vitamin D deficiency with cardiovascular disease among Saudi patients in Saudi Arabia. Int J Prev Med [serial online] 2020 [cited 2021 Jan 23];11:191. Available from: https://www.ijpvmjournal.net/text.asp?2020/11/1/191/303218
| Introduction|| |
Vitamin D is essential for human health, it is derived from sterol by the exposure of sunlight. Other major sources of vitamin D are natural food and fortified food. A high prevalence (from 30% to 50%) of vitamin D among world population. Countries in which population living near to equator line more likely to vitamin D deficiency. Cardiovascular disease (CVD) is a major public health problem and the leading cause of death worldwide, and it is estimated that 17.7 million deaths occur from CVD. There are many factors that contribute to the development of CVD. The nutritional factor is one of the most important factors which caused CVD.
There are several studies that determined the association of vitamin D deficiency with CVD.,, One of the previous studies found that vitamin D deficiency is associated with hypertension. One of the previous studies in the USA shows that the prevalence of CVDs is remarkably high in subjects with deficient vitamin D levels. Common risk factors for CVD, such as obesity, higher blood pressure, low high-density lipoprotein (HDL) cholesterol, insulin resistance, type 2 diabetes (T2D), high parathyroid hormone, dyslipidemia, hypertension, and urine albumin creatinine ratio (UACR) are discussed in this study.,,,, In another US study, where 7674 participants' results showed that low vitamin D status has significant risk of development of CVD, in American adults. Another American study found that vitamin D deficiency had direct association with angina, myocardial infarction (MI), and stroke.
In another study reported that vitamin D deficiency associated with hypertension (HTN) and CVD. Another study in which a 10-year follow-up for the elderly population consumed decreased intake of vitamin D and increase probability of acute MI and stroke. Several meta-analyses show that vitamin D deficiency had association with CVD cases.,,, In previous study, found that vitamin D deficiency had absolute risk for CVD among male gender. Other study concluded that lower serum 25 [OH] vitamin D levels were significantly associated with elevated levels of systolic blood pressure (SBP) (β = −0.07) and DBP (β = −0.06).
Another study observed that improvements in 101 CVD patient outcomes after 6 weeks of vitamin D supplementation at the rate of 2000 IU. Another study reported that there were improved cardiac functions in 229 patients of chronic heart disease after 4000 IU of vitamin D in 1 year.
In Saudi Arabia, to the knowledge of the researcher there is very few literature available about relationship of vitamin D deficiency with CVD. This study is expected to help identify the factors of vitamin D deficiency which contribute to CVD, and it is also expected to help improve measures and policymaking for prevention of these diseases.
| Methods|| |
Study setting, study design, and sampling technique
The study was conducted in a major tertiary care hospital in urban city of Kingdom of Saudi Arabia. This hospital average 1000 beds and daily patients' turnover of out-patient department is average 10,000. Participants were recruited from the department of cardiology. The study design was cross-sectional study. Participants were selected with simple random sampling. First, hospital record is taken from the hospital (inpatient, outpatient, ICU). Make a frame list of patents from the hospital record then selected the required study participants through random number from random number computer software. The independent variable is the serum vitamin D3 level, risk factors for CVD (e.g., diabetes and lipid profile), and certain comorbidities (e.g., cerebrovascular disease) while the dependent variables included CVD (e.g., ischemic heart disease and HTN),
Inclusion criteria and exclusion criteria
Confirmed cardiac patients by medical and laboratory tests. Those who have their serum vitamin D levels available in their medical records. Exclusion criteria: Those nationals who belong to other countries were excluded. Patients whose vitamin D levels are not available in their medical records.
The sample size was calculated for the prevalence of obesity, as one of the CVD risk factors in the proposed study. A sample size of 360 was fulfilled to detect a difference of 12% in the prevalence of obesity between low vitamin D level (<20 ng/mL) and the high vitamin D level with the power of 80% and the level of significance at 5%. The prevalence of obesity was considered as 24% in low vitamin level and 12% in high vitamin level.
Data collection tool and technique
Study participants selected from the hospital which is diagnosed cases of CVD from the inpatient, outpatients, and ICU. All patient's information included disease diagnosis, his personal, biochemical, hematological, and clinical data of all the CVD patients were retrieved from electronic medical records of the hospital, with the help of a study collaborator from the hospital. Personal data included patients' age, gender, height, and weight. Biochemical parameters such as lipid profile—triglycerides (TG), low-density lipoprotein (LDL), HDL, in addition to SBP , diastolic blood pressure (DBP), HbA1c, and serum 25 [OH] vitamin D3 levels were retrieved. Vitamin D serum level was measured through serum 25[OH] D test.
The research proposal was approved by the Institutional review board (IRB) of the Imam Abdul Rehman bin Faisal University and IRB no is PGS-2019-01-197. The confidentiality of patients was maintained. The informed consent was taken before starting the interview.
Statistical package for social sciences (SPSS version 23) was used for data entry and statistical analysis of study variables. Descriptive statistics (frequency and percentages) for categorical variables and mean and standard deviation for quantitative variables were calculated. The normality of data was checked through Kolmogorov-Smirnov Test. A Chi-square test was used to determine the difference between two subgroups such as male and female. For dichotomous outcomes, the odds ratio (OR) with 95% confidence interval (CI) was computed and compared. To determine the association of outcome variable and independent variable, logistic regression was used. P value was calculated at the 5% level of significance.
| Results|| |
The mean age of study participants was 61 years (±10 years). More (56.1%) than half of them between 61–85 years and 55.6% were females. The percentage of abnormal HbA1c, high blood glucose level, high random blood glucose level, hypercholesterolemia, low HDL level, high LDL level, diabetes, and hypertension, ischemic heart disease were 48.15%, 6.5%, 23.6%, 16.4%, 33.9%, 27.5%, 86.9%, 62.8%, 11.9%, 74.7%, and 18.1%, respectively [Table 1].
[Table 2] shows the prevalence of vitamin D deficiency among participants. Vitamin D deficiency, insufficiency, and normal serum level of vitamin D were 40.6%, 27.8%, and 31.7%, respectively.
In univariate analysis, diabetic patients were significantly associated with vitamin D deficiency and insufficiency, but other factors are statistically insignificant [Table 3].
|Table 3: Association of vitamin D deficiency with clinical characteristics of study participants (Univariate analysis)|
Click here to view
After adjustment of covariate, age group between 61 and 85 years had OR 3.16 (1.29–7.73) three times more likely association with vitamin D deficiency among cardiac patients, those who have abnormal triglyceride had OR 2.27 (1.22–4.22) more than two times more likely association with vitamin D deficiency among cardiac patients. Cardiac patients with diabetic had OR 1.32 (1.05–5.69) more than one time likely association with vitamin D deficiency [Table 4].
|Table 4: Association of vitamin D deficiency with clinical characteristics of study participants (multivariate analysis (n=360)|
Click here to view
Cardiac patients were two times more likely associated with vitamin D deficiency and insufficiency. OR 1.99 (0.88–4.46) and OR 2.20 (1.05–4.61) respectively [Table 5].
|Table 5: Association of vitamin D insufficiency and deficiency with cardiovascular diseases among participants|
Click here to view
[Figure 1] shows the association of vitamin D levels with different types of CVDs.
| Discussion|| |
The result of the study found a strong positive association of vitamin D deficiency with CVD patients. Cardiac patients with age above 60 years, female gender, diabetic, hypertension, and abnormal lipid profile had more likely vitamin D deficiency.
Female cardiac patients were more vitamin D deficient in this study. This result is consistent with the previous study. The reasons for this deficiency are lack of exposure to sunlight due to covering of body and hormonal changes.
In this study, result found that cardiac patients with abnormal Hb1c were more likely associated with vitamin D deficiency. This result is consistent with previous study which found that diabetes was associated with vitamin D deficiency since pancreatic function becomes affected with vitamin D deficiency. Cardiac patients with abnormal fasting and random blood glucose levels were associated with vitamin D deficiency in this study. Several other studies also showed positive associations of high fasting and random blood glucose level among CVD patients with vitamin deficiency., This study found that high blood cholesterol levels among CVD patients are most likely associated with vitamin D deficiency. This result contrasted with those of previous studies,, which showed that this association was not accounted for the low level of vitamin D among obese patients. The scientific reason is that low levels of parathyroid hormones increase the levels of intracellular calcium in adipocytes, which lead to obesity due to lipogenesis. A previous study of randomized controlled trial, vitamin D supplementation of 30000 IU/week for 1 year to a group of people aged between 20 and 65 years, resulted in no change of body weight after intervention of vitamin D. Cardiac patients with diabetes were associated with vitamin deficiency in this study, and these results also consist of previous study which found that CVD and diabetes are more likely associated with each other. The reason is that diabetes causes pathologic changes in the body like clotting of blood and structure changes in the heart which caused CVD.
There are several points of strength of this study. It is the first study was conducted in the eastern province of Saudi Arabia that explores the association of heart disease and its risk factors associated with vitamin D deficiency. Second, a standardized data collection protocol was followed in addition to rigorous control of quality throughout the study from design to write-up. There were several limitations of this study, first, the cross-sectional study design, which cannot determine the exact causal inference or temporality of association between variables. Second, sample size was small which reduced the generalizability of results.
| Conclusions|| |
The finding of this study suggested that risk factors of vitamin D among cardiac patients should be monitored to prevent the consequences of CVD. Health promotion should be developed to increase awareness among general population, specifically heart disease patients regarding vitamin D deficiency.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: A narrative review. Clinical Hypertension 2018;24:9.
Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al
. Effect of vitamin D supplementation on blood pressure: A systematic review and meta-analysis incorporating individual. Patient data. JAMA Intern Med 2015;175:745-54.
Kimlin MG. Geographic location and vitamin D synthesis. Mol Aspects Med 2008;29:453-61.
Zittermann A. Vitamin D in preventive medicine: Are we ignoring the evidence? Br J Nutr 2003;89:552-72.
Holick MF. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-71.
Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al
. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 2010;65:225-36.
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007;85:1586-91.
Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, et al
. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118:1950-61.
Al Shaikh AM, Abaalkhail B, Soliman A, Kaddam I, Aseri K, Al Saleh Y, et al
. Prevalence of vitamin D deficiency and calcium homeostasis in Saudi children. J Clin Res Pediatr Endocrinol 2016;8:461-7.
Tamez H, Kalim S, Thadhani RI. Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens 2013;22:204-9.
Scragg RK, Camargo CA Jr, Simpson RU. Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the national health and nutrition examinations surveys). Am J Cardiol 2010;105:122-8.
Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, et al
. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J 2013;166:357-64.e2.
Liu L, Chen M, Hankins SR, Nùñez AE, Watson RA, Weinstock PJ, et al
.; Drexel Cardiovascular Health Collaborative Education, Research, and Evaluation Group. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol 2012;110:834-9.
Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary Reference Intake for Calcium and Vitamin D. Washington, DC, USA: National Academies Press; 2011.
Alkerwi A, Sauvageot N, Gilson G, Stranges S. Prevalence and correlates of vitamin D deficiency and insufficiency in Luxembourg adults: Evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study. Nutrients 2015;7:6780-96.
Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, et al
. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: Dose-response meta-analysis of prospective studies. Am J Clin Nutr 2017;105:810-9.
Al-Khalidi B, Kimball SM, Rotondi MA, Ardern CI. Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: A cross-sectional analysis of NHANES, 2001-2010. Nutr J 2017;16:16.
Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 2009;205:255-60.
Ke L, Mason RS, Mpofu E, Vingren JL, Li Y, Graubard BI, et al
. Hypertension and other cardiovascular risk factors are associated with vitamin D deficiency in an urban Chinese population: A short report. J Steroid Biochem Mol Biol 2017;173:286-91.
Marniemi J, Alanen E, Impivaara O, Seppänen R, Hakala P, Rajala T, et al
. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005;15:188-97.
Clark AN, Mankikar GD, Gray I. Diogenes syndrome: A clinical study of gross neglect in old age. Lancet 1975;305:366-8.
Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19:13-9.
Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nature Reviews Cardiology 2016;13:404.
Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005;48:1247-57.
Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am 2012;38:179-206.
Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007;157:225-32.
Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199-201.
Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008;159:675-84.
Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: Results from three large prospective cohort studies. Hypertension 2005;46:676-82.
Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001;86:1633-7.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-38.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]